Fetus and Newborn

Sep 5, 2018 ‐ Sep 8, 2018


COMMERCIAL SUPPORT

  • Chiesi
  • Mallinckrodt Pharmaceuticals 

     

2.  DISCLOSURE OF COMMERCIAL RELATIONSHIPS

    Consistent with Contemporary Forums' policy, faculty members are required to disclose any potential conflicts of interest.

Faculty Member

Company/Organization

Affiliation

David H. Adamkin, MD

None

None

William E. Benitz, MD

None

None

Jeanne Carroll, MD

None

None

Marcus Davey, PhD

None

None

Avroy A. Fanaroff, MD

None

None

Jonathan M. Fanaroff, MD, JD

None

None

Jay P. Goldsmith, MD

None

None

Jose A. Honold, MD

None

None

Jae H. Kim, MD, PhD

#1: Medela

#2: Mead Johnson

#3: Abbott Nutrition

#1Consultant, Advisor | Human milk

#2: Speaker | Nutrition

#3: Speaker | Nutrition

Sandra Leibel, MD

None

None

Angela Lierman, MS, NNP

None

None

Gilbert I. Martin, MD

None

None

Richard J. Martin, MD

#1: Windtree Pharmaceuticals [formerly Discovery Labs]

#2: CareFusion

#1 Chair, Data Safety Monitoring Board

#2 Chair, Data Safety Monitoring Board

Christopher C. McPherson, PharmD

None

None

Richard A. Polin, MD

None

None

Elizabeth Schierholz, MSN, RN, NNP-BC

None

None

Michael L. Segall, MD

None

None

Harjit Sull-Garewal, JD

None

None

Mandhir S. Suri, MD, FAAP

None

None

Denise M. Suttner, MD

None

None

Kristin C. Voos, MD, FAAP

None

None

Kelly C. Wade, MD, PhD, MSCE

None

None

Carol Wallman DNP, APRN, NNP-BC

None

None

Standard: $525.00

Sessions

#51* Do Intermittent Hypoxic Episodes in Preemies Matter? (Rx = .5 Hr.) ACPE #0263-000-18-963-L01-P (1.25 Contact Hrs.)

Sep 7, 2018 11:15am ‐ Sep 7, 2018 12:30pm

Identification: CCS51

Credits: None available.

Learning Objectives:

  • To recognize the challenges associated with documenting intermittent hypoxia
  • To appreciate the potential interaction between oxidant stress, inflammation, and neonatal morbidity
  • To consider the challenge of pre-discharge monitoring

Speaker(s):
Standard: $12.00

#52 Nuts & Bolts of Creating Family Centered Care ACPE #0263-000-18-964-L01-P (1.25 Contact Hrs.)

Sep 7, 2018 11:15am ‐ Sep 7, 2018 12:30pm

Identification: CCS52

Credits: None available.

Learning Objectives:

  • Apply tools for family engagement
  • Construct plans for parent support programs

Speaker(s):
Standard: $12.00

#53 Optimization of Ventilation in a Neonate – Old School vs. New School (Rx = .5 Hr.) ACPE #0263-000-18-965-L01-P (1.25 Contact Hrs.)

Sep 7, 2018 11:15am ‐ Sep 7, 2018 12:30pm

Identification: CCS53

Credits: None available.

Learning Objectives:

  • Discuss pathophysiology and pathogenesis of lung injury
  • Discuss strategies to prevent lung injury
  • Discuss future directions.

Speaker(s):
Standard: $12.00

#54 Feeding Babies on Non-Invasive Ventilation ACPE #0263-000-18-966-L01-P (1.25 Contact Hrs.)

Sep 7, 2018 11:15am ‐ Sep 7, 2018 12:30pm

Identification: CCS54

Credits: None available.

Learning Objectives:

  • Evaluate when an infant is ready to orally feed
  • Provide oral feedings to the preterm infant on NIV via breast and/or bottle
  • Reduce the incidence of oral aversion in preterm babies on NIV

Speaker(s):
Standard: $12.00

Clinical Application of Genomics in Neonatology ACPE #0263-000-18-967-L01-P (.75 Contact Hr.)

Sep 7, 2018 1:45pm ‐ Sep 7, 2018 2:30pm

Identification: FRI145

Credits: None available.

Learning Objectives:

  • Discuss the evidence supporting the diagnostic utility of clinical whole genome sequencing in the NICU
  • Review the evidence for potential cost savings of whole genome sequencing in neonates
  • Identify characteristics of clinical cases where rWGS may provide valuable information allowing for precision medicine

Speaker(s):
Standard: $12.00

Mastering the Magic of Mothers’ Milk in the NICU (Rx = .5 Hr.) ACPE #0263-000-18-968-L01-P (.75 Contact Hr.)

Sep 7, 2018 2:30pm ‐ Sep 7, 2018 3:15pm

Identification: FRI230

Credits: None available.

Learning Objectives:

  • List the known benefits of mother’s milk to preterm infant
  • Identify the most common challenges in the management of mother’s milk In the NICU
  • Outline the approach to developing a Supporting Premature Infant Nutrition program in your NICU

Speaker(s):
  • Jae H. Kim, MD, PhD, Rady Children's Hospital San Diego
Standard: $12.00

Principles of Family Parent Engagement ACPE #0263-000-18-969-L01-P (.75 Contact Hr.)

Sep 7, 2018 3:30pm ‐ Sep 7, 2018 4:15pm

Identification: FRI330

Credits: None available.

Learning Objectives:

  • Describe the Family-Centered Care (FCC)/Family Engagment Core Principles and outcomes
  • Recognize examples of applying family engagement principles

Speaker(s):
Standard: $12.00

Minimizing Antibiotic Exposure in Infants at Risk for Early Onset Sepsis (Rx = .25 Hr.) ACPE #0263-000-18-970-L01-P (1.25 Contact Hrs.) & Questions and Discussion (Rx=.25 Hr.)

Sep 7, 2018 4:15pm ‐ Sep 7, 2018 5:30pm

Identification: FRI415

Credits: None available.

Learning Objectives:

  • Describe strategies for selective antibiotic use in neonates at risk for early-onset sepsis
  • Discuss the rationales for antibiotic choices for empiric treatment for suspected sepsis in neonates according to the clinical circumstance
  • Understand evidence-based criteria for timely discontinuation of antibiotics when infection is not confirmed

Speaker(s):
Standard: $12.00

The Oxygen Controversy: Why Can’t Neonatologists Get It Correct? ACPE #0263-000-18-971-L01-P (.75 Contact Hr.)

Sep 8, 2018 8:00am ‐ Sep 8, 2018 8:45am

Identification: SAT800

Credits: None available.

Learning Objectives:

  • Understand the risks and benefits of early caffeine therapy
  • Know the risks and benefits of sustained lung inflation
  • Understand the potential benefits of Less Invasive Surfactant Administration

Speaker(s):
Standard: $12.00

To Treat or Not To Treat: Management Of PDA (Rx = .75 Hr.) ACPE #0263-000-18-972-L01-P (.75 Contact Hr.)

Sep 8, 2018 8:45am ‐ Sep 8, 2018 9:30am

Identification: SAT845

Credits: None available.

Learning Objectives:

  • Describe the natural history of PDA closure in preterm infants.
  • Describe the evidence supporting medical interventions to close persistent PDA in preterm infants
  • Discuss the consequences of treating fewer preterm infants to close PDA

Speaker(s):
Standard: $12.00
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content